Team

Nightbox runs lean. One founder, one production AI agent stack. The agent is treated as research infrastructure — not a teammate, not a co-founder, but a reproducible computational platform.

Artem Shakin

Founder & CEO

Computational biology and gene therapy. Founded Nightbox LLC in February 2026 with the conviction that comparative cancer biology — particularly the elephant LIF6 mechanism — has been under-utilized as a therapeutic platform. Designs constructs, runs the AI agent stack, manages all R&D and business development.

Contact: artem@nightboxllc.com · @ArtemShkin

AI Research Agent

Production R&D infrastructure

Claude-based agent stack running on Vercel Edge. Designs chimeric constructs, runs freedom-to-operate scans, drafts patent claims, monitors competitive intelligence across NKG2D and LIF6 prior art, and powers the public-facing chat on this site that can answer technical questions about NKG2D-LIF6 in real time.

Hiring

We will be hiring a wet-lab scientific lead in Q2 2026 to oversee in vivo validation. If you have AAV / gene therapy / mouse oncology experience and want to work on something genuinely first-in-class with high autonomy, please reach out.